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In  a  preceding  study  (2)  concerning  the  mechanism  by which  influenza 
viral infection of the mouse induces susceptibility to secondary pneumococ~l 
pneumonia evidence was presented that this susceptibility is associated  with 
the appearance  of the lesion produced by the virus. The studies reported in the 
present paper indicate that pulmonary edema is a component of the influenza 
viral lesion in the mouse and that the presence of fluid in the lung is an im- 
portant factor in the inception  of pneumococcal  pneumonia in this animal. 
In addition, evidence is presented that the chief action of fluid under these 
circumstances is to furnish a culture medium for growth of pneumococci. 
Methods and Materials 
Details of techniques have been described in earlier papers (2, 3). Mice were infected with 
the Weiss strain of influenza virus and the A5 strain of Type I  pneumococcus.  1 The intrabron- 
chial method of inoculation was used not only for the virus but also for introducing fluids or 
cultures into the lung. In addition, mice were allowed to inhale fine droplets containing pneu- 
mococci and were observed for survival or were killed and the pneumocoecal content of the 
left lobe of the lung determined by grinding the tissue in a mortar and preparing poured blood 
agar plates. 
Although pulmonary fluid could be seen in microscopic sections stained with hematoxylin 
and  eosin,  other staining procedures  rendered fluid more easily and certainly visible. Iron 
hematoxylin (5) and phloxin with methylene blue (6) were used for this purpose and some un- 
differentiation of the latter was permitted. Pneumococci in the lung were visualized well with 
eosin and methylene blue (6) or Giemsa (6). 
Reexpansion of lungs with fixative was carried out as before in order to see the structure of 
the lung adequately (7). However, because of the possibility that introduction of fixative into 
* This study was supported by the Commonwealth Fund. 
:~ A  preliminary report was presented at the meeting of the Central Society for Clinical 
Research, October 31, 1947 (1). 
1 In one experiment, the 8  HCC  strain of Type  III pneumococcus was  employed.  This 
strain is the same as that utilized in other experiments in this laboratory (4). 
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the trachea might alter the locations of fluid or bacteria, control sections of unexpanded lungs 
were observed also. No significant difference due to reexpansion was detected. 
For experimental induction of pulmonary fluid, sterile normal mouse serum was administered 
intrabronchially. In order to fill a large number of alveoli with fluid by this method, the amount 
of inoculum delivered from the cannula was doubled. Since the capacity of the cannula was 
0.05 ml., this double amount was obtained by increasing the amount of serum injected into the 
cannula from 0.1 ml. to 0.15 ml. 
Pulmonary edema in mice was induced by alpha naphthyl thiourea  (ANTU).  2 This drug 
was ground finely in a mortar and suspensions in olive oil were administered intraperitoneally. 
Because of variation in the time of death after inoculation of the drug, groups of mice in each 
experiment were injected with doses varying  from 0.5 mg. to 4.5 mg. Only animals dying within 
4 to 6 hours after administration of the drug were selected for the experimental procedures. 
In some experiments, a solution of 10,000 units of crystalline penicillin G in 0.1 ml. of saline 
was injected intramuscularly. For determination of the number of pneumococci in lungs of 
mice injected with penicillin, 10 units of penicillinase  s was added to each poured blood agar 
plate. 
EXPERIMENTAL PROCEDURES AND  RESULTS 
Pulmonary Edema in the Viral Lesion.--For microscopic study of the viral 
lesion, lethal or sublethal doses of influenza virus were injected intrabronchially 
into mice and sections of consolidated lungs were prepared after 5 days; that 
is, at the same time after inoculation that growth of inhaled pneumococci in 
the viral lesion had been demonstrated. Examination of these sections showed 
the lesion of viral pneumonia and it was noticed that a  prominent component 
of the lesion consisted of pulmonary edema (Fig. 1). 
It was found that fluid could be demonstrated in some of the alveoli of practically every 
section with viral pneumonia of 5 days duration. The fluid first appeared at about the same 
time that macroscopic  lesions of the lung became visible and, in mice with sublethal infections, 
fluid persisted for at least 30 days after inoculation. Frequently the largest amounts of fluid 
were not in areas of greatest cellular infiltration of the tissue, and the impression was gained 
that the distribution of fluid in the lung was determined to a large extent by gravity. 
Experimental Induction of Pulmonary E,  dema4.--The  presence of fluid in the 
lung as a part of the lesion of influenza viral pneumonia in the mouse suggested 
that  inhaled pneumococci might  become  implanted in  such  fluid  and  find 
conditions favorable for rapid growth. It was thought that a  way to test this 
possibility would be  to  induce pulmonary edema in the  mouse without  the 
other components of the influenza viral lesion and to test the susceptibility of 
such mice to inhaled pneumococci. However, inasmuch as the viral lesion is an 
inflammatory process,  it  was  necessary  to  have  a  means  for  induction of 
pulmonary fluid that did not owe its effect to an irritation of the tissues. 
2 Kindly furnished by E. I. du Pont de Nemours and Co., Inc. 
3 Obtained from Shenley Laboratories, Inc., 350 Fifth Avenue, New York. 
In this paper, the term pulmonary edema is used to denote fluid in the lung regardless 
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In order to meet these requirements,  sterile normal mouse serum was admin- 
istered  intrabronchially  to  mice  and  the  presence  of serum  in  the  lung  was 
confirmed by microscopic sections. That this serum would persist long enough 
in  the  lung to allow  tests  of susceptibility  to pneumococci was indicated  by 
the work of others who have shown that protein-containing fluids are removed 
slowly from the lung chiefly by the lymphatics,  in contrast with crystalloidal 
solutions  which  are  absorbed  rapidly  into  the  blood  stream  (8-11).  Fig.  2 
shows the appearance  of pulmonary edema due to intrabronchial  injection of 
serum. 
Rarely were more than half the alveoli filled with serum in a given section. The fluid was 
present not only in the alveoli but also in the lymphatics and interstitial  tissues. Significant 
amounts  of fluid were present in the alveoli 7 hours after injection and fluid was detected in 
the air sacs even 24 hours later. 
Another  method  employed  5  to  cause  accumulation  of  fluid  in  the  lung 
involved the use of alpha naphthyl thiourea  (ANTU). 
When this drug is administered to animals death from pulmonary edema results from a selec- 
tive effect on the capillaries of the lung rendering them permeable to plasma proteins (12,13). 
In trials with ANTU in mice, efforts were made to adjust the dose so that animals would have 
a degree of pulmonary edema compatible with survival. It was found, however, that sublethal 
doses of ANTU failed to cause fluid to collect in the alveoli although fluid was present in the 
lymphatics and interstitial tissues. On the other hand, lethal doses were followed by pulmonary 
edema with involvement not only of interstitial  tissues but also of considerable numbers of 
alveoli. 
Fig. 3 shows the miscroscopic appearance of the lung of a mouse dying from a 
lethal dose of ANTU. 
Although these two methods of inducing pulmonary edema appeared  to be 
without an irritant  effect on the lung, it was desirable  to substantiate  lack of 
inflammation  by histologic methods.  Sections  of mouse  lungs  after  injection 
of serum were examined for the presence of inflammatory cells but no signifi- 
cant numbers were found within  the early hours after injection.  However, 24 
hours after inoculation there was an increase in alveolar macrophages and some 
sections  showed  the  findings  of spontaneous  secondary bacterial  pneumonia. 
Microscopic sections of the lungs of mice dying from ANTU showed pulmonary 
edema but no cellular evidence of inflammation. 
Pneumococcal Infection of Mice with Injected Pulmonary Fluid.--In order to 
test  the effect of pulmonary edema on susceptibility of mice to inhaled pneu- 
mococci, sterile  normal mouse  serum was injected  intrabronchially  into mice 
5 Unsuccessful attempts to produce histologically demonstrable pulmonary edema in the 
mouse  included  administration  of lethal  amounts  of ether,  chloral  hydrate,  piloearpine, 
histamine, and a glucoside of digitalis. Asphyxia as well as compression of the chest, abdomen, 
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and  immediately  after  inoculation  the  animals  were  allowed  to  inhale  fine 
droplets containing pneumococci for  1  hour.  As controls in each  experiment 
normal mice, mice injected with saline, or mice subjected to cannulation without 
injection of fluid inhaled the bacteria in the chamber at the same time. The 
results shown in Table I  indicate that mice with pulmonary fluid induced by 
this method have increased susceptibility to infection by inhaled pneumococci. 
Growth of Pneumococci  in Lungs with Injected Pulmonary Fluid.--It seemed 
likely that  the increased susceptibility of mice with injected pulmonary fluid 
was  due  to  growth  of  pneumococci  in  this  fluid.  In  order  to  learn  whether 
growth  actually occurred  in  such  lungs,  mice were  injected  intrabronchially 
with serum,  allowed to inhale pneumococci, and  the bacterial content  of the 
TABLE I 
Fatal Infection of Mice Inhaling Pneumococcl after Intrabronchial Injection of Serum 
Experiment 
No. 
Intrabronchial 
injection 
Serum 
None 
Serum 
Saline 
Serum 
None§ 
Died* 
17 
1 
18 
9 
11 
4 
Survived~ 
17 
3 
13 
9 
14 
Total  Chi square 
19  22.8  18 
21  7.4  22 
20  3.0  t8 
* Shown to be fatal pneumococcal infection by recovery of the organism in every instance. 
:~ Killed after 11 to 14 days and culture of each lung failed to show pneumococci. 
§ Mice were anesthetized and the cannula was passed into the bronchus but no inoculum 
was injected. 
lung was determined immediately and 6  hours later. The results presented in 
Table II show that pneumococci multiply in the lung under these circumstances. 
In determining the number of pneumococci in the lungs of mice inhaling this organism after 
intrabronchlal injection of sterile serum, it was found that contaminating organisms were more 
numerous  and frequent than in similar determinations with normal mice or mice with in- 
fluenza viral infection.  Nearly every plate showed at least a few contaminating colonies and, 
when any doubt existed as to the identity of colonies, pneumococci were demonstrated by 
capsular swelling with Type I antiserum. In Table II, all plates are represented and those show- 
ing enough contaminants to render the counts  of pneumococei doubtful are designated  and 
excluded from the statistical calculations. 
Pneumococci are known to be capable of growth in normal serum (14). In separate con- 
firmatory tests, normal mouse  serum was inoculated with small numbers of pneumococci 
and determinations made of the number of pneumococci present by means of poured blood 
agar plates. By this procedure, significant growth was demonstrated within 3 hours. 
As in the previous work showing that pneumococci would grow in the viral lesion (2), there A 
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was need to exclude the possibility that pneumococci might grow elsewhere in the body and 
be transported to the lung by the blood. Therefore, mice were injected intrabronehially with 
serum, allowed to inhale pneumococci, and 6 hours later determinations were made of the 
pneumococeal content of the blood and left lobe of the lung of each mouse. The absence of 
bacteria from the blood in nearly all instances gave further evidence of primary pneumococeal 
growth in the lung. 
Pneumococcal Content of Lungs with Pulmonary Edema Due to ANTU.--Mice 
with pulmonary fluid due to this drug were tested for susceptibility to inhaled 
pneumococci  because  it  was  thought  that  endogenous  fluid  arising  from  a 
drug administered systemically would have minimal irritating properties and 
would  be more closely comparable than serum to the pulmonary fluid of the 
viral  lesion.  Also,  contaminating  bacteria  from  intrabronchial  inoculation 
would not be present in endogenous pulmonary fluid. However, for ANTU to 
cause  collection of fluid  in  the  alveoli,  it  was necessary to administer  lethal 
doses of the drug, as already stated, and test for susceptibility to pneumococci 
by determining  the  bacterial  content  of the  lung.  Therefore,  lethal doses of 
ANTU  were  administered  to  mice  and  immediately thereafter  the  animals 
were allowed to inhale fine droplets containing pneumococci for 1 hour. Normal 
mice for control were allowed to inhale pneumococci in the chamber at the same 
time. Bacterial counts were made on the left lobes of mice dying of pulmonary 
edema 4 to 6 hours after injection of ANTU. Animals dying before 4 hours or 
after 6 hours were discarded.  Whenever the bacterial content of the lung of a 
mouse with pulmonary edema was determined, a  control mouse was killed at 
the same time and a similar count done for comparison. The results are shown 
in  Table III  where  it  may  be seen that  lungs  of mice dying of pulmonary 
edema contained more pneumococci than those of control mice. 
While  it  appeared  probable  that  the  greater  number  of pneumococci  in 
lungs  with pulmonary edema due  to ANTU was caused  by growth  of these 
bacteria in edema fluid, the possibility remained that this difference was brought 
about  by interference  with  mechanisms  for elimination  of  inhaled  bacteria. 
To obtain evidence bearing on this point, advantage was taken of the fact that 
penicillin is known to act only on growing bacteria (15-19). 
Mice were injected with ANTU as already described and immediately thereafter half of 
them were treated with penicillin. All the mice were then allowed to inhale fine droplets of 
pneumococci for 1 hour in the chamber at the same time and the pneumococcal  content of the 
left lobe of the lung was determined in mice dying between 4 and 6 hours later. Penicillinase 
was used in the poured blood agar plates of mice treated with penicillin. The results of these 
experiments are shown in Table IV. 
It is apparent from the table that treatment with penicillin caused a diminu- 
tion  in  the  pneumococcal content  of the  lung  with  pulmonary edema.  It  is 
concluded, therefore, that the lung with pulmonary edema supports the growth 
of inhaled pneumococci in contrast with the normal lung in which growth does 
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That endogenous fluid induced by ANTU would  support rapid growth of 
pneumococci was indicated by testing in vitro the pleural fluid of mice dying 
from this drug. The fluid,  collected  aseptically and prevented from clotting 
with heparin,  was inoculated with small numbers of pneumococci  and  the 
bacterial content tested before  and after incubation for 3 hours.  Significant 
growth of pneumococci occurred  under these conditions.  Also, ANTU placed 
directly in fluid culture medium did not inhibit growth of pneumococci. 
Further evidence suggested that ANTU does not inhibit mechanisms of the 
lung for elimination of bacteria. The effect of ANTU on movement of bronchial 
cilia was tested by a  direct method for observation of these structures to be 
described in a subsequent paper. Visualization  of cilia in lungs of mice dying 
from  ANTU  showed  active  movement.  Furthermore,  exposure  in  vitro  of 
fresh slices of lung to the small amount of ANTU in a saturated solution  in 
saline had no apparent effect on movement of bronchial cilia. In addition, it has 
TABLE IV 
Effect of Penicillin on  the Growth of Inhaled [Pneumococci in Lungs of Mice Dying from 
ANTU 
J 
Experiment ]  Drug treatment  Plate counts 
~n.  I 
[  0  6  2  238  8  632361,5  4  13,547  0  21 
ANTU  plus  peni-  2  0  0  2  1  0  0  2  0  0  0  t  0 
2  ci[lin* 
ANTU*  9  37  4  >5  2  4  2  3  2  1  1  5  44323314 
Statistical 
evaluation~ 
0, 
14.5 
15. 
5. 
3.1 
114. 
* Ten units of~venicillinase were added to each plate. 
~; As in Table IL 
already been reported that lymphatic flow  is increased in animals injected with 
ANTU (11, 20) and this condition might be expected to result in fewer numbers 
of pneumococci remaining in the lung than normal. 
Production of the Lesion of Bacterial Pneumonia by Serum and Pneumococci.-- 
Having shown that the edematous lung will allow the growth of pneumococci, 
it was important to know whether the lesion of bacterial pneumonia would 
result from such growth. Therefore,  pneumococci suspended  in normal mouse 
serum were injected intrabronchiaUy  into mice and sections of the lungs pre- 
pared about 24 hours later. It was found that the lesion of bacterial pneumonia 
was produced in nearly every instance; masses of polymorphonuclear leucocytes 
were present in the alveoli and interstitial tissues. Many of these leucocytes 
were degenerated and showed karyorrhexis of nuclei. In some areas edema fluid 
was seen and pneumococci were often found there in large numbers.  In other 
experiments,  normal mouse serum was injected intrabronchially and the mice 
were allowed to inhale pneumococci for 1 hour. Sections were prepared at the 
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was present although less frequently and to a  milder extent than when the 
pneumococci  were suspended in the serum. A pneumococcal lesion thus produced 
is shown in Fig. 4. 
In order to administer pneumococci without fluid as a control, mice were allowed to inhale 
the organism in the form of fine droplets. Type III pneumococci were used for this purpose 
because of the known greater pulmonary virulence of this type of pneumococcus (21). Type 
I pneumococci  were used also and in this case inhalation  was permitted to continue  for 4 hours 
so as to overcome the pulmonary  resistance previously shown for this strain. With both strains 
of pneumococcJ,  some of the mice developed general infection 2 to 11 days after inhalation  and 
sections of the lung were prepared when the mice were moribund or immediately after death. 
Microscopic examination of such lungs showed no lesions of pneumonia and the appearance 
under low power of the microscope was that of the normal lung (Fig. 5). Under the oil immer- 
sion objective, large numbers of pneumococci were found particularly in the pulmonary  blood 
vessels (Fig. 6). 
Paucity of Early Phagocytosis in t~ Lung.--Because  it is known that phago- 
cytosis is an important means of resistance to pneumococcal infections in the 
lung  (22),  a  microscopic study was  carried  out  to  evaluate  the  phagocytic 
mechanism  in the earliest stages of pneumonia  caused by pneumococci suspended 
in serum. Cultures of pneumococci were subjected to angle centrifugation and 
the bacterial sediments were  suspended in normal mouse serum. Such heavy 
suspensions of bacteria in serum were injected intrabronchially into mice and 
microscopic sections were  prepared  immediately thereafter  and  at  intervals 
for 6 hours. 
In the normal lung of the mouse, only occasional potymorphonuclear leucocytes are seen 
and these are chiefly in the capillaries of the alveolar walls or in the larger blood vessels. 
After injection of pneumococci in serum, fluid and bacteria were seen in the alveoli and inter- 
stitial tissues. Three hours later many more pneumococci were visible, apparently growing in 
the pulmonary fluid (Fig. 7), but not until this time did significant numbers of polymorpho- 
nuclear leucocytes begin to appear. At 3 hours, these phagocytes were present in larger num- 
bers in the interstitial tissues and a few could be seen entering the alveoli. During the period 
from 3 to 6 hours a progressive increase in the numbers of polymorphonuclear leucocytes was 
seen. Essentially no phagocytosis of pneumococci by polymorphonuclear leucocytes was ob- 
served during the first 3 hours and only moderate phagocytosis from 3 to 6 hours. 
In sections of normal mouse lungs, macrophages are found regularly but not all the alveoli 
contain them. Small numbers of these cells are present also in the interstitial tissues. After 
intrabronchial  injections of heavy suspensions of pneumococd in serum, the number of macro- 
phages present did not appear to increase significantly after the first 6 hours. In addition, dur- 
ing the first 3 hours, it was noted that remarkably little phagocytods took place. Although 
some macrophages were found to contain a few pneumococd, most of the organisms were seen 
in the pulmonary  fluid outside of macrophages. The degree of phagocytosis exhibited by macro- 
phages is illustrated in Fig. 8. In this alveolus, pneumococci are demonstrable within a macro- 
phage but many other pneumococci in the same alveolus are extracellular. 
The possibility arose that the large numbers  of pneumooocci  produced leucotoxic substances 
that caused a slow and inefficient phagocytosis by macrophages. For this reason, heat-killed 
pneumococd were washed in Locke's solution, suspended in serum, and injected as before, 
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Lungs with influenza viral lesions of 5 days duration have cellular infiltration with mono- 
nuclear cells including macrophages in the interstitial tissues and in addition many macro- 
phages are present in the alveoli. The number of polymorphonuclear  leucocytes in such lungs 
varies greatly. In some sections, polymorphonuclear leucocytes are rare and gradations in 
number occur so that, in some other sections, large numbers of these cells are found and the 
appearance is that of secondary bacterial pneumonia. However, aerobic and anaerobic cultures 
of such lungs usually do not reveal a secondarily infecting bacterium. Because of the large 
numbers of phagocytic cells already present in the lung with fully developed viral pneumonia, 
we have found it dif]~cult to evaluate the phagocytic mechanism after injection of large 
numbers of pneumococci  suspended in normal mouse serum. Nevertheless, it has been possible 
to show that some phagocytosis takes place both by polymorphonuclear leucocytes and by 
macrophages. However, we have gained the impression that migration of polymorphonuclear 
leucocytes and macrophages is no faster in the lung with a viral lesion than in the normal 
lung. Also, the rate of phagocytosis by macrophages in the lung with a viral lesion appears to 
be about the same as the rate in the normal lung. 
The  results  of  microscopic study  of  the  earliest  phases  of  the  infectious 
process resulting  from intrabronchial  injection  of pneumococci suspended  in 
serum  showed  that  there  was  a  significant  delay  in  the  migration  of poly- 
morphonuclear  leucocytes and  macrophages into  the  infected lung.  Further- 
more,  the  macrophages already present  in  the  normal  lung  engulfed pneu- 
mococci at a slow rate. Although evaluation of phagocytosis in the lung with a 
viral lesion  was  more difficult,  a  comparable insufficiency of the  phagocytic 
mechanism appeared to exist. 
DISCUSSION 
The  evidence  presented  indicates  that  the  presence  of  pulmonary  edema 
under the conditions studied is a  decisive host factor in determining whether 
inhaled  pneumococci will  grow  in  the  lung,  produce  the  lesion  of bacterial 
pneumonia,  and cause death of the animal.  Inhaled pneumococci were elimi- 
nated rapidly from the lung of the normal mouse, pneumonia did not occur, 
and most of the animals survived (2,  3). This influence of pulmonary fluid on 
the inception of pneumonia is to be distinguished from the transporting effect 
of edema fluid in lungs already the site of bacterial infection (23-35, 7), although 
spread of pneumonia by the latter mechanism may be considered inception of 
pneumonia in the new areas (29). The implications of the present experiments 
are that the presence of a nutrient fluid favors the initiation of pneumococcal 
infection of the lung and that the genesis of the fluid need not be due to reaction 
from the bacterium itself. 
It  is  necessary  to  assume  that  inhaled  pneumococci  grow  in  pulmonary 
fluid just as bacteria grow in fluid culture media, since growth of the organism 
took place in the lung only in the presence of fluid. Furthermore,  serum and 
pleural  fluid of mice were shown to support rapid growth from small inocula 
of pneumococci in vflro. On the other hand, pulmonary fluid is not demonstrable 
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might be present would not be sufficient to support growth of pneumococci since 
growth has been shown not to occur. 
Data recorded in the previous paper demonstrated that inhaled pneumococci 
grow in a mouse lung with influenzal pneumonia and the present observations 
show similar growth in the lung with pulmonary fluid without the other com- 
ponents of the viral lesion. In view of these facts, it appears that the pulmonary 
edema of the influenza viral lesion  e accounts adequately for growth of inhaled 
pneumococci in the viral lesion. Furthermore, pulmonary fluid in a  sublethal 
viral lesion would explain the greater than normal susceptibility of such mice 
to general pneumococcal infection after inhalation of these organisms. In either 
the lung with viral pneumonia or the lung with experimentally induced pulmo- 
nary fluid, the rate of growth of inhaled pneumococci must be rapid enough 
to make it possible for the bacterial content of the lung to increase in spite 
of factors that tend to eliminate bacteria such as ciliary action, phagocytosis, 
and  lymphatic  drainage.  However,  it  is  possible  that  these  antibacterial 
mechanisms of the lung are also impaired by the viral lesion. 
There is evidence that progress or arrest  of pneumococcal pneumonia de- 
pends on whether or not the organisms can grow faster in the edema fluid than 
elimination can take place through phagocytosis (27, 31). In the present studies 
on inception of pneumonia, it has been shown not only that  the presence of 
pulmonary fluid enables pneumococci to grow but also that there is a significant 
delay in appearance of polymorphonuclear leucocytes. Pneumococci grow in the 
body fluids of the mouse within 3 hours, but even with the maximal stimulus 
of  many  of  these  organisms  polymorphonuclear leucocytes do  not  migrate 
into the lung during this time.  ~ This delay in appearance of phagocytic cells 
may be due to a  diluting effect of the edema fluid on the toxic products of 
pneumococci. However, regardless of its mechanism, delayed arrival of leuco- 
cytes under these  circumstances is similar in its end result to the inhibition 
of migration of leucocytes due to anesthesia with ether or alcohol (44) in that 
time is permitted for growth of the organisms. 
Macrophages are not abundant in the alveoli of the normal mouse lung and 
in addition were found to engulf pneumococci too slowly to have a significant 
retarding effect on bacterial growth in alveolar fluid. This slow action of the 
pulmonary macrophages indicates that these ceils are not efficient as a first-line 
defense in the mouse lung and that polymorphonuclear leucocytes must act in 
6 In descriptions  of the microscopic  lesion  in influenzal  pneumonia of the mouse, the presence 
of pulmonary fluid has been noted before (36-43). 
7 In experimental pneumonia of monkeys, Loosli (33) observed the migration of poly- 
morphonuclear leucocytes  into the infectious focus in the lung as early as 1½ hours after in- 
jection of pneumococci  suspended in a mixture of starch and broth. Probably, the more rapid 
migration of leucocytes under these circumstances was due to the irritant nature of the in- 
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this capacity. A similar slow action of macrophages has been found in experi- 
mental pneumococcal lymphadenitis of rats  (45).  However, in this situation, 
migration of polymorphonuclear leucocytes is more rapid than in the normal 
mouse lung and suggests some difference in capillary permeability in  these 
two sites. 
One might expect that a lung with fully developed influenza viral pneumonia 
would have a more efficient immediate phagocytic mechanism than the normal 
lung  because  polymorphonuclear leucocytes are  often  present  already and 
macrophages are abundant. The fact that inhaled pneumococci grow in the lung 
with a  viral lesion would not invalidate this hypothesis since rapid growth of 
pneumococci in pulmonary fluid could result in a  net increase  of bacteria  in 
spite of the destruction of some organisms by phagocytosis. 
The  question arises  as  to  what  effect pulmonary fluid may have  on  the 
phagocytic properties of macrophages already present in the normal lung or 
macrophages and polymorphonuclear leucocytes in the viral lesion. It seems 
likely that fluid in the alveoli could interfere with phagocytosis because it has 
been shown that pneumococci floating freely in fluid away from alveolar wails 
are not ingested because the phagocytes are unable to trap the floating organ- 
isms against a  suitable surface (46). 
No histologic evidence of inflammation was detected within several hours 
after the induction of pulmonary edema so that the effect on susceptibility to 
bacteria cannot be attributed to irritation from the experimental procedures. 
It might be argued that only the fluid component of an inflammatory process 
(47,  48) was present and was not detected histologically but, if this were so, 
it  would support  our  concept  concerning the  effect of pulmonary fluid. In 
addition, it seems probable that the mechanism by which injection of irritating 
substances facilitates initiation of pneumococcal pneumonia (25, 49, 33) is by 
causing  the fluid component of inflammation to enter  the alveoli.  Further- 
more, the production of pneumonia in animals by injection of pneumococci 
alone (50) may be due to a similar reaction from the organisms themselves. 
Although it is recognized that conditions in mice may not be strictly com- 
parable to those in human beings, it seems likely that the concept of pulmonary 
fluid as an important factor in susceptibility to pneumonia may be valid in 
human beings also since secondary pneumonia is especially frequent in diseases 
often complicated by pulmonary edema. In this connection it is noteworthy 
that  pulmonary edema  was  a  characteristic  feature  of pandemic  influenza 
(51) and it has been suggested as a  contributing cause of secondary bacterial 
pneumonia in this disease (52). 8  That edema fluid in the human lung may furnish 
8  The etiology  of pandemic  influenza  is unknown  and most reports of pulmonary  lesions  in 
influenza are complicated by the presence of bacterial pneumonia. However, a case of fatal 
influenza has been reported apparently without secondary bacterial infection  and in which 
pulmonary fluid was a prominent feature of the lesions (53). In this instance, the virus was 
recovered from the lung and significant  bacteria were absent. C. G. IIARFORD  AND  ~. I~ARA  257 
a  favorable medium for proliferation of bacteria has been suggested as a  pre- 
disposing factor in the pneumonias that follow congestive heart failure (54) * 
and  shock  (52).  1°  Finally,  it  should  be  mentioned  that  secondary bacterial 
infection  is  characteristic  in  conditions  elsewhere  than  the  lung  in  which 
abnormal  amounts  of  fluid  accumulate  such  as  nephrotic  ascites  (57)  and 
lymphedema (58). In such cases, it seems probable that growth of bacteria in 
the fluid is an important factor in lowered resistance to bacterial infection. 
SUMMARY 
Pulmonary edema  is  a  component  of  the  fully developed  influenza  viral 
lesion in the mouse. 
Mice with experimental pulmonary fluid have an increased susceptibility to 
inhaled pneumococci and under these circumstances the organisms grow in the 
lung and produce the lesion of bacterial pneumonia. 
The presence of pulmonary edema in the lesion due to the influenza virus 
in  the  lung  of  the  mouse  appears  to  account  adequately  for  the  previous 
observation that inhaled pneumococci grow in the influenza viral lesion. 
Mice dying of pneumococcal septicemia after inhaling fine droplets contain- 
ing this organism do not have pneumonia. 
The delay in migration of polymorphonuclear leucocytes into the tung after 
injection of pneumococci suspended  in serum is  an important  factor in sus- 
ceptibility to infection since it allows ample time for pneumococci to grow in 
the pulmonary fluid. 
The  slow  phagocytic action  of pulmonary macrophages  likewise  permits 
growth of pneumococci. 
Conditions in human beings that are known to be complicated by pulmonary 
edema are also known to be associated with increased susceptibility to secondary 
bacterial pneumonia. 
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EXPLANATION OF PLATES 
Sections were photographed by Mr. Cramer Lewis. 
PI~T~-  13 
FIG. 1.  Pulmonary edema in a lesion due to influenza virus 5 days after inoculation. 
Hematoxylin and eosin.  ×  100. 
FIG. 2.  Pulmonary edema due to intrabronchial injection of serum.  Phloxin and 
methylene blue.  X  100. 
FIG. 3.  Pulmonary  edema  due  to  ANTU.  Note  dilated lymphatic vessels.  Iron 
hematoxytin.  X  100. 
FIc. 4.  Pneumococcal  pneumonia  in  a  mouse  from  intrabronchial  injection  of 
pneumococci suspended in normal mouse serum. Hematoxylin and eosin.  ×  100. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL, 91  PLATE  13 
(Harford and Hara: Pulmonary edema and pneumonia) PLATE 14 
Fro. 5.  Lack of pneumonic exudate in a mouse moribund from septicemia 7 days 
after inhalation of Type I pneumococci. Eosin and methylene blue. ×  100. 
FIG. 6.  Type III pneumococci in pulmonary blood vessel of mouse dying of sep- 
ticemia 6 days after inhalation of this strain of bacteria. Giemsa.  ×  1200. 
FIG. 7.  Pneumococci apparently  growing  in  alveolar  fluid  4  hours  after  intra- 
bronchial injection of many organisms suspended in normal mouse serum. Note the 
absence of polymorphonuclear leucocytes. Eosin and methylene blue.  ×  400. 
FIG. 8.  Phagocytosis of only one pair of pneumococci by an alveolar macrophage 4 
hours after intrabronchial injection of the organism suspended in serum. Numerous 
unphagocyted pneumococci are present in the same alveolus and polymorphonuclear 
eucocytes are absent. Taken from the same section as Fig. 7.  ×  1200. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 91  PLATE  14 
(Harford and Hara: Pulmonary edema and pneumonia) 